Sign in
4

Changes in Ownership

HARROW, INC. Filed Acc 0001493152-24-036244

CEO of ImprimisRx gave up 45,140 shares (to pay taxes)

  • CEO of ImprimisRx acquired 90,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

SAHAREK JOHN P. · CEO of ImprimisRx

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-11 Exercise or conversion : show line 1 in the form +90,000 $7.37 $663,300 344,803 D
2024-09-11 Shares withheld for taxes : show line 2 in the form −45,140 $41.37 $1,867,442 299,663 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-09-11 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −90,000 0 D
Loading xslF345X05/ownership.xml…